| 3. MANUFACTURING OPERATIONS - ACTIVE SUBSTANCES |
Active Substance:Magnesium chloride hexahydrate Starting material: <confidential> |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.3 Salt formation / Purification steps: Hydrat formation, Filtration, Separation, Crystallisation
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
| 3.6.4 Biological Testing |
|
Active Substance:Potassium iodide Starting material: <confidential> |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.3 Salt formation / Purification steps: Salt formation, Filtration, Separation, Crystallisation
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
|
Active Substance:Thiamine phosphoric acid ester chloride dihydrate Starting material: <confidential> |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: Salt formation, Crystallisation
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, homogenization
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
|
Active Substance:Urea Starting material: <confidential> |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.3 Salt formation / Purification steps: Filtration, Crystallisation
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, homogenization
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:Sodium chloride Starting material: <confidential> |
|
3.5
|
General Finishing Steps
|
| |
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
| 3.6.4 Biological Testing |
|
Active Substance:Boric acid Starting material: <confidential> |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.3 Salt formation / Purification steps: Filtration, Crystallisation
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
|
Active Substance:Cocarboxylase chloride Starting material: <confidential> |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: Salt formation, Crystalisation
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, homogenization
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
| 3.6.4 Biological Testing |
|
Active Substance:Cocarboxylase tetrahydrate Starting material: <confidential> |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: Crystallisation, Hydrate formation
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, homogenization
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
| 3.6.4 Biological Testing |
|
Active Substance:Di-Potassium hydrogen phosphate anhydrous Starting material: <confidential> |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.3 Salt formation / Purification steps: Salt formation, Filtration, Crystallisastion
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, homogenization
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
| 3.6.4 Biological Testing |
|
Active Substance:Tri-sodium citrate dihydrate Starting material: <confidential> |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.3 Salt formation / Purification steps: Salt formation, Filtration, Separation, Crystallisation
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
| 3.6.4 Biological Testing |
|
Active Substance:Calcium chloride dihydrate Starting material: <confidential> |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.3 Salt formation / Purification steps: Filtration, Crystallisation
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, homogenization
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
| 3.6.4 Biological Testing |
|
Active Substance:Tepotinib Starting material: <confidential> |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.1 Manufacture of active substance intermediates |
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: crystallization
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|